Saposin C: Neuronal Effect and CNS Delivery by Liposomes
暂无分享,去创建一个
Ying Sun | Xiaoyang Qi | Ying Sun | C. Kuan | X. Qi | G. Grabowski | Zhengtao Chu | Chia Yi Kuan | Gregory A Grabowski | Zhengtao Chu
[1] D. Wenger,et al. Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts. , 1986, The Journal of biological chemistry.
[2] J. O'brien,et al. Prosaposin prevents programmed cell death of rat cerebellar granule neurons in culture. , 1998, Brain research. Developmental brain research.
[3] E. Cornford,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Delivery of Compounds across the Bbb: Strategies and Methods New Systems for Delivery of Drugs to the Brain in Neurological Disease , 2022 .
[4] H. You,et al. Phospholipid membrane interactions of saposin C: in situ atomic force microscopic study. , 2003, Biophysical journal.
[5] X. Qi,et al. Conformational and amino acid residue requirements for the saposin C neuritogenic effect. , 1999, Biochemistry.
[6] Ying Wang,et al. Phospholipid vesicle fusion induced by saposin C. , 2003, Archives of biochemistry and biophysics.
[7] W. Pardridge,et al. Drug and Gene Delivery to the Brain The Vascular Route , 2002, Neuron.
[8] B. Martin,et al. The effect of carbohydrate removal on stability and activity of saposin B. , 1993, Archives of biochemistry and biophysics.
[9] Ying Sun,et al. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase. , 2002, Molecular genetics and metabolism.
[10] K. Suzuki,et al. Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice) , 1998, Acta Neuropathologica.
[11] D. Ginty,et al. Retrograde neurotrophin signaling: Trk-ing along the axon , 2002, Current Opinion in Neurobiology.
[12] A. Serafino,et al. Saposin C induces pH‐dependent destabilization and fusion of phosphatidylserine‐containing vesicles , 1994, FEBS letters.
[13] Xiaoyang Qi,et al. Saposin C-LBPA interaction in late-endosomes/lysosomes. , 2005, Experimental cell research.
[14] W. Qin,et al. Functional Organization of Saposin C , 1996, The Journal of Biological Chemistry.
[15] Y. Kishimoto,et al. Binding and transport of gangliosides by prosaposin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Poulos,et al. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidoses , 1989, European Journal of Pediatrics.
[17] A. Poulos,et al. Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts. , 1990, European journal of cell biology.
[18] R. Parton,et al. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function , 1998, Nature.
[19] M. Elleder,et al. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. , 2001, Human molecular genetics.
[20] Ying Sun,et al. Prosaposin: threshold rescue and analysis of the "neuritogenic" region in transgenic mice. , 2002, Molecular genetics and metabolism.
[21] J. O'brien,et al. Induction of MAPK phosphorylation by prosaposin and prosaptide in PC12 cells. , 1996, Biochemical and biophysical research communications.
[22] K. Sandhoff,et al. Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator. , 1989, Journal of biochemistry.
[23] K. Suzuki,et al. Sphingolipid activator proteins. , 1995, Essays in biochemistry.
[24] B. Martin,et al. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. , 1997, Archives of biochemistry and biophysics.
[25] F. Sanmartí,et al. Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant , 1999, Acta Neuropathologica.
[26] X. Qi,et al. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase. , 1994, The Journal of biological chemistry.
[27] W. Möbius,et al. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor. , 1997, European journal of cell biology.
[28] Greg Grabowski,et al. Proteolytic Processing Patterns of Prosaposin in Insect and Mammalian Cells* , 1996, The Journal of Biological Chemistry.
[29] Y. Kishimoto,et al. Identification of prosaposin as a neurotrophic factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Weiler,et al. Identification of the neurotrophic factor sequence of prosaposin , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] P. Rakic,et al. Requirement of the JIP1 scaffold protein for stress-induced JNK activation. , 2001, Genes & development.
[32] S. Emr,et al. Receptor downregulation and multivesicular-body sorting , 2002, Nature Reviews Molecular Cell Biology.
[33] H. You,et al. Phospholipid membrane restructuring induced by saposin C: a topographic study using atomic force microscopy , 2001, FEBS letters.
[34] Y. Kishimoto,et al. Saposins: structure, function, distribution, and molecular genetics. , 1992, Journal of lipid research.
[35] N. Maeda,et al. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. , 1996, Human molecular genetics.
[36] C. Morales,et al. Biogenesis of lysosomes by endocytic flow of plasma membrane. , 1999, Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al.
[37] D. Wenger,et al. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts. , 1986, Biochimica et biophysica acta.
[38] S. Ueno,et al. A Hydrophilic Peptide Comprising 18 Amino Acid Residues of the Prosaposin Sequence Has Neurotrophic Activity In Vitro and In Vivo , 1996, Journal of neurochemistry.
[39] P. Rakic,et al. A critical role of neural-specific JNK3 for ischemic apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[40] B. Martin,et al. Prosaposin receptor: evidence for a G-protein-associated receptor. , 1997, Biochemical and biophysical research communications.
[41] B. Maras,et al. Structural Analysis of Saposin C and B , 1995, The Journal of Biological Chemistry.
[42] G. Grabowski,et al. Molecular cloning of a human co-β-glucosidase cDNA: Evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats ☆ , 1989 .
[43] X. Qi,et al. Fusogenic domain and lysines in saposin C. , 2004, Archives of biochemistry and biophysics.
[44] X. Qi,et al. Differential Membrane Interactions of Saposins A and C , 2001, The Journal of Biological Chemistry.
[45] S. Ueno,et al. Prosaposin Facilitates Sciatic Nerve Regeneration In Vivo , 1996, Journal of neurochemistry.